Results 1 to 10 of about 313,149 (366)

Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study.

open access: yesPLoS ONE, 2022
BackgroundThe role of antibiotics in the treatment of Shiga toxin-producing Escherichia coli (STEC) infection is controversial.ObjectivesTo evaluate the association between treatment (antibiotics, antidiarrheal agents, and probiotics) for STEC infection ...
Shota Myojin   +12 more
doaj   +1 more source

Isolation and characterization Shiga toxin-producing Escherichia coli from sheep and goats inJordanwith evidence of multiresistant serotype O157:H7

open access: yesVeterinární Medicína, 2005
Ninety-three rectal swabs of lambs and young goats from two extensively and two intensively managed herds in Jordanwere taken and examined for Shiga toxin-producing Escherichia coli (STEC).
R. Novotna   +5 more
doaj   +1 more source

Epidemiology of Shiga toxin-producing Escherichia coli O157:H7 in Africa in review

open access: yesSouthern African Journal of Infectious Diseases, 2018
Shiga toxin-producing Escherichia coli (STEC) O157:H7 is responsible for intestinal and extra-intestinal disease syndromes in human. Isolation of the pathogen from animals, food, clinical samples and environment has been reported from all continents.
Athumani M. Lupindu
doaj   +1 more source

Atypical hemolytic uremic syndrome [PDF]

open access: yes, 2011
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. Atypical HUS (aHUS) defines non Shiga-toxin-HUS and even if some authors include secondary aHUS due to Streptococcus pneumoniae
Chantal Loirat   +1 more
core   +2 more sources

Effect of ultrasound pretreatment on structural, physicochemical, rheological and gelation properties of transglutaminase cross-linked whey protein soluble aggregates

open access: yesUltrasonics Sonochemistry, 2021
A solution (10%, w/v) of whey protein soluble aggregates (WPISA) was pretreated with high-intensity ultrasound (HUS, 20 kHz) for different durations (10–40 min) before incubation with transglutaminase (TGase) to investigate the effect of HUS on the ...
Tiehua Zhang   +5 more
doaj   +1 more source

Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls [PDF]

open access: yes, 2014
Background: Shiga toxin (Stx)-producing Escherichia coli (STEC) infection is associated with hemolytic uremic syndrome (HUS), the main cause of acute renal failure in early childhood.
Guirro, Mirian   +3 more
core   +2 more sources

Ockham’s razor defeated: about two atypical cases of hemolytic uremic syndrome

open access: yesBMC Nephrology, 2020
Background Medical investigation is a favorite application of Ockham’s razor, in virtue of which when presented with competing hypotheses, the solution with the fewest assumptions should be privileged. Hemolytic uremic syndrome (HUS) encompasses diseases
Chloe Schwarz   +11 more
doaj   +1 more source

Incidence and cost of haemolytic uraemic syndrome in urban China: a national population-based analysis

open access: yesBMC Nephrology, 2022
Background Haemolytic uraemic syndrome (HUS) is a severe syndrome that causes a substantial burden for patients and their families and is the leading cause of acute kidney injury in children. However, data on the epidemiology and disease burden of HUS in
Jingnan Feng   +12 more
doaj   +1 more source

Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood

open access: yesFrontiers in Pediatrics, 2018
Introduction: Hemolytic-uremic syndrome (HUS) is a common cause for intrarenal acute kidney injury in childhood. More than 90% of HUS cases are associated with an infection by Shigatoxin-producing Escherichia coli (STEC) whereas the reminder comprises a ...
Laura Vaterodt   +4 more
doaj   +1 more source

Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report

open access: yesBMC Nephrology, 2019
Background Haemolytic uraemic syndrome (HUS) is a thrombotic microangiopathy (TMA) characterized by predominant renal involvement. Several types of HUS can be distinguished: the most frequent « typical » HUS, due to shiga toxin producing Escherichia coli
Stéphane Bally   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy